Fat Melting Startup Raziel Therapeutics Raises $22 Million
The company's drug is injected into subcutaneous fat where it causes immediate fat cell death at the injection site, resulting in a reduction of fat tissue
Adi Pick | 13:30 19.12.2019
Central Israel-based pharmaceutical company Raziel Therapeutics Ltd. has raised a $22 million series C funding round, the company announced Wednesday. The round was led by Pontifax, with participation from Catalyst Fund, Quark venture, Peregrine Investments, Wille AG, and existing investors.